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Cl o s t r i d i u m p er f r i n g en s
Infections in Baby Calves
Russ Daly, DVM, Extension Veterinarian
Lori Rotert, Pre-Veterinary Student

Illnesses and death losses in baby calves are significant problems for producers raising calves in beef or
dairy operations. Several of these issues, especially
sudden deaths and certain enteric (intestinal) conditions, are potential effects of infections due to
Clostridium perfringens. Clostridium perfringens are
Gram-positive, spore-forming, anaerobic bacteria that
are very commonly found in many environments,
including soil, water, poorly preserved feeds, contaminated or improperly thawed colostrum or milk, calfhousing environments, and the normal bovine intestinal tract. In small amounts, these bacteria are generally
harmless in the intestine, but under the right conditions
they may grow and proliferate, resulting in en t er ot oxem ia , a condition in which specific toxins produced by
the bacteria in the small intestine result in both local
damage and systemic (whole body) effects.

Pathogenesis: How C. perfringens causes disease
Because of the widespread nature of the organism,
calves are readily exposed to C. perfringens in their
environment and commonly ingest the bacteria in various quantities, after which it enters the stomach and
intestine. Sometimes bacteria are ingested in sufficient
quantities to cause disease, but oftentimes small quantities are ingested, followed by rapid proliferation in the
intestine.

Enterotoxemia due to C. perfringens is more likely to
affect baby calves (within the first two months of age)
than mature cattle because the calves lack a fully functioning rumen. C. perfringens feeds on starches and
sugars in the small intestine. In mature cattle, these

starches and sugars are predominantly digested in the
rumen, so they are not available to the C. perfringens
microbes for use. However, in baby calves, nearly all
feed bypasses the rumen and is digested in the abomasum (true stomach) and the small intestine, so the
starches are available for the microbes to feed on. This,
coupled with a normal intestinal flora that has not yet
developed, provides a suitable environment for the C.
perfringens to proliferate. Several factors can contribute to this rapid proliferation. Primary among these
are abrupt changes in feeding patterns (see
“Prevention” below), physical or environmental stress,
nutritional deficiencies, and conditions that impair
movement of the intestine (such as diarrhea due to other
causes).
As C. perfringens proliferates in the gut, the bacteria
secrete toxins that have profound effects not only on the
local intestinal environment (causing damage to the
intestinal lining), but throughout the body as well.
Death occurs when high levels of these bacterial toxins
enter the bloodstream, leading to inflammation, shock,
and cardiac arrest. C. perfringens is not spread from
calf to calf, but it is not uncommon for several calves in
a group to be affected at the same time, due to similar
exposure and management practices.

Types of C. p er f r i n g en s
There are five types of C. perfringens (see Table 1
below), designated A through E, which are identified
based on the toxins they produce. It is the effect of these
specific toxins that results in the clinical signs and syndrome attributable to each type.

Table 1. C. perfringens types, major toxins, and associated syndromes

TOXIN TYPE

MAJOR TOXIN

A

Alpha

B

Beta, Alpha, Epsilon

C

Beta, Alpha

D

Epsilon, Alpha

E

Iota, Alpha

SYNDROMES
1. Abomastitis (stomach inflammation) in calves
2. Bloating in calves
3. Mild diarrhea in calves
4. May be associated with hemorrhagic bowel
syndrome (HBS) in dairy cattle
1. Hemorrhagic enteritis in newborn calves
(NOT FOUND IN U.S.)
1. Sudden death in very young calves
2. Hemorrhagic enteritis (bloody scours)
1. Enterotoxemia resulting in sudden death,
usually in calves on feed (finishing cattle)
1. Fatal enterotoxemia in newborn calves

Typ e C is one of the more commonly encountered
types of C. perfringens. It is especially virulent in
calves less than 10 days old (and often less than five
days old). Enterotoxemia due to C. perfringens Type C
may result in severe bloody diarrhea, although oftentimes calves die before diarrhea develops.

Typ e B is almost non-existent and has not been found
in North America.

Diagnosis of C. perfringens
Necropsy of the calf, in cases of Types C and E, will
sometimes reveal severe necrosis (tissue damage) and
hemorrhage in the small intestine. Calves affected with
Type A will often show inflammation, ulceration, and
hemorrhage of the lining of the rumen and abomasum.
Because C. perfringens is often found in the intestine of
normal calves, a simple culture of the organism from
the calf is not sufficient by itself to confirm a diagnosis
of disease due to C. perfringens. Culture results are
matched with clinical signs, lesions in the tissues, and,
in some cases, toxin identification, to obtain a true
diagnosis. Tissue samples from calves suspected of
having clostridial enterotoxemia should be collected
soon after death and kept well-preserved (after the
death of the calf, normal populations of clostridial
organisms can overgrow and confuse diagnosis).

Clostridium perfringens Typ e A has been increasingly identified as a cause of abomasal inflammation,
which may result in abdominal distension (bloating) or
abomasal ulcers in young calves. Varying degrees of
diarrhea, and occasionally sudden onset of weakness
and coma, have also been associated with Type A,
which generally affects a slightly older (2-4 weeks old)
calf. It is also occasionally associated with wound contamination and gas gangrene. Diagnosis of Type A
enterotoxemia can be difficult due to the fact that it is a
very common inhabitant of the normal intestinal tract;
therefore, culture results need to be matched to clinical
signs and lesions in the tissues (see “Diagnosis” below).

TREATMENT
The treatment of syndromes caused by C. perfringens
is frequently unsuccessful. Because clinical signs are
usually a result of the toxin, not the bacteria itself, treatment with antibiotics (which act solely on the bacteria
and not the toxins) is often less than rewarding. In addition, with many of these syndromes, death or severe illness occurs before treatment can even be attempted;
therefore, early detection becomes essential if treatment
is to be successful.

Enterotoxemia due to C. perfringens Typ e D is sometimes associated with sudden death in finishing cattle
because it proliferates when there are high amounts of
carbohydrates available in the diet, which is often the
case in cattle being fed high amounts of grain in finishing diets.
Typ e E enterotoxemia has been diagnosed, although
infrequently, in South Dakota calves. It causes a severe
local intestinal necrosis and systemic toxemia similar to
the syndrome described with Type C.
2

occasionally D) bacterin-toxoids. A separate vaccine
against Type A antigens has been conditionally licensed
and is available. Since vaccines for Type C (against the
beta toxin) do not cross-protect against other types
(other toxins), and while not expressly labeled for this
use, this vaccine has been used in cows pre-calving to
try to maximize colostral protection against Type A
enterotoxemia (alpha toxin).

Typical treatments for calves with milder clinical signs
consist largely of antibiotics (especially penicillin) and
the use of C. perfringens antitoxin products. Several
injectable antitoxin preparations that contain specific
antibodies directed against toxins produced by C. perfringens are currently available. While these antitoxin
products are developed expressly for use against toxins
produced by Types C and D (beta and epsilon toxins),
there may be some effect against alpha toxin (Type A)
as well. Supportive care with oral or IV fluids and antiinflammatories may also be indicated. Any treatment
plan needs to be developed in close consultation with
the herd veterinarian.

Along with colostral antibodies, antitoxin preparations, as mentioned above, are available. In certain situations of excessive exposure, these products may be
administered to calves at birth in an attempt to prevent
clinical disease.

PREVENTION
Prevention of enterotoxemia due to C. perfringens
infection focuses on three areas: 1) minimizing exposure, 2) enhancing immunity in the young calf, and 3)
managing feeding practices to discourage the proliferation of C. perfringens in the gut.

Active vaccination of young calves with C. perfringens vaccines (such as 7-ways or 2-ways containing
Types C and D, or the Type A vaccine) is frequently
attempted, but little is known about how these vaccines
perform in very young (<1 month) calves. Again, these
vaccines do not offer protection against the other types
(other toxins) not included in the vaccine.

1) M in im izin g exp osu r e Despite the fact that clostridial organisms are ubiquitous in the calf’s environment,
the more organisms a newborn calf is exposed to the
more likely it is to succumb to disease. For that reason,
careful attention must be paid to sanitation of the calving area, whether it be a maternity pen in a dairy or a
calving pen in a beef operation. Buildup of all enteric
pathogens occurs when the same calving area is used
throughout the calving season, as these organisms are
generally very hardy in the environment.

3) M a n a gin g feed in g p r a ct ices While cow-calf producers have very little control over their calves’ feeding
practices, those raising calves (e.g., dairy calves in
hutches) have complete control over their calves’
dietary intake. In those operations, it is extremely
important to follow strict calf-feeding guidelines. C.
perfringens overgrowth in the intestine is aided by any
of the following:
• Milk replacer is improperly mixed (too much or too
little water added).
• Milk replacer is incompletely mixed (clumps of powder still present at feeding).
• Additives such as electrolytes are added to the milk
replacer, creating excessive osmolarity or sodium
concentrations.
• The temperature of milk replacer is too high or low
when the calf is fed. Milk replacer temperature should
be close to the calf’s body temperature (~101° F).
• Feeding schedules are erratic. Regular, consistent
schedules and delivery methods (bucket vs. bottle)
are important in avoiding clostridial overgrowth.
• Changes in diets are made suddenly.
• Calves drink too quickly (e.g., nipple opening is too
large).
• Equipment (buckets, bottles, nipples, etc.) becomes
contaminated due to lack of hygiene.

2) En h a n cin g im mu n it y Colostral (passive) immunity
is of utmost importance in the resistance of calves to C.
perfringens enterotoxemia, since these calves are generally too young (and clinical signs occur too early) to
respond to active vaccination. Antibodies against C.
perfringens and its toxins are passed from dam to calf
through colostrum. Calves should consume an adequate amount (4 quarts) of high-quality colostrum
within the first 18-24 hours of life to gain maximum
protection.
A strategy for maximizing colostral antibody levels is
vaccinating the dam before she calves. Vaccines against
clostridial diseases are typically “bacterin-toxoids,”
meaning that the vaccine is meant to stimulate a
response against both the bacteria and the toxin produced by the bacteria. Several pre-calving vaccines
(“scour shots”) contain C. perfringens Type C (and
3

Clostridial infections have been and will continue to
be significant challenges to beef and dairy producers.
Attention must be paid to all aspects of the disease,
including the newborn calf’s environment, immunity,

and feeding practices. With these aspects in mind, and
with close consultation with a veterinarian, it is possible to manage and minimize the effect of these syndromes in our operations today.
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